http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S63255257-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_47f5b48ea632d303b95ef7d183a4ab0c
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C253-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C255-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K19-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02F1-13
filingDate 1987-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ff07e072c9191e5f8dba4887129e2bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84828525fe42fde48e99b006fc4a881a
publicationDate 1988-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S63255257-A
titleOfInvention Optically active cyanobiphenyl compound
abstract NEW MATERIAL:A compound expressed by the formula [n is 3W5: R is -(CH 2 ) a - CH 3 or formula II (a and b are 3W12); * indicates asymmetric carbon]. n EXAMPLE: 4-(6"-Chloro-4"-methylhexyloxy)-4'-cyanobiphenyl. n USE: A liquid crystal display element substance having a low crystal-liquid crystal phase transition point and a high liquid crystal-isotropic liquid phase transition point in providing a cholesteric phase. n PREPARATION: For example, 4-hydroxy-4'-cyanobiphenyl is subjected to etherification reaction with a halide or citrate of an optically active alcohol in the presence of an alkaline compound to afford the aimed compound expressed by the formula. n COPYRIGHT: (C)1988,JPO&Japio
priorityDate 1987-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5695977-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226461828
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID140610
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14496131
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235694207

Total number of triples: 20.